Category: Nanomedicine
Asia Nanomedicine
-
Nanomedicine Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Indication (Oncology, Infectious Disease, Cardiology, Neurological Disease); By Application (Drug Delivery, Regenerative Medicine, Vaccines, Active Implants); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA))
... America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)) Global Nanomedicine Therapeutics Market Size Booming at CAGR of 9.42% to Surpass Whopping USD 369 Billion by 2030 Global Nanomedicine Therapeutics Market ... Read More
-
Lipid Nanoparticle Manufacturing Market: Services and Technologies, 2023-2035 - Distribution by Type of Lipid Nanoparticle (Solid Lipid Nanoparticles and Nanostructured Lipid Carriers), Type of Molecule Delivered (Nucleic Acids, Small Molecules, Proteins/Peptides and Others), Company Size (Very Large and Large, Mid-sized and Small), Target Therapeutic Area (Infectious Diseases, Oncological Disorders, Blood Disorders, Rare Diseases and Other Disorders), Type of End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-users) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts
... (Very Large and Large, Mid-sized and Small), Target Therapeutic Area (Infectious Diseases, Oncological Disorders, Blood Disorders, Rare Diseases and Other Disorders), Type of End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-users) ... Read More
-
Injectable Nanomedicines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global demand for injectable nanomedicines is witnessing significant growth, driven by advancements in nanotechnology that enhance drug safety and efficacy. These nanomedicines are designed to release drugs at targeted sites, allowing for the accumulation of ... Read More
-
Nanoparticle Contract Manufacturing (Focus on Lipid and Metal Nanoparticles) Market by Company Size (Very Small, Small, Mid-sized and Large), Type of Nanoparticle(s) Manufactured (Lipid and Metal Nanoparticles), Scale of Operation (Preclinical, Clinical and Commercial), Type of End User (Educational Institutions, Pharmaceutical Companies, Research Institutions, and Other End Users), and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2021-2035
... of End User (Educational Institutions, Pharmaceutical Companies, Research Institutions, and Other End Users), and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends ... Read More
-
Post-pandemic Healthcare Business Models in APAC—2023
... innovative business models. Several challenges, such as personnel burnout, the lack of experienced staff, inflation leading to increased care costs, healthcare accessibility disparities, and the rise of chronic diseases and aging population, are significant catalysts ... Read More
-
India Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “India Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Russia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Russia Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Russia Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
South Korea Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterin
... Summary GlobalData’s “South Korea Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the South Korea Embolization Particle Procedures. The databook report provides procedure volumes within segments - ... Read More
-
Asia-Pacific (APAC) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea
... Summary GlobalData’s “Asia-Pacific Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Asia-Pacific Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle ... Read More
-
China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “China Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the China Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Japan Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Bioactive Materials Market, By Material Type (Bioactive Glass, Bioactive Ceramics, Bioactive Composites, Other Material Types), By Application (Dental Care, Nanomedicines and Biotechnology, Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Bioactive materials have many different uses, including tissue engineering, regenerative medicine, diagnostics, and wound repair. They can also have applications in cancer therapy ... Read More
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Middle East and Asia Pacific Biotechnology Market, by Technology (Nanobiotechnology, Tissue Engineering and Regeneration, Fermentation, Cell Based Assay, CRISPR, and Others ), by Application (Molecular Biology, Gene Synthesis, Gene Editing, Mammalian Prot
... Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) ... Read More
-
Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) -
... 2022 - 2028 Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government ... Read More
-
Middle East and Asia Pacific Biotechnology Market, by Technology (Nanobiotechnology, Tissue Engineering and Regeneration, Fermentation, Cell Based Assay, CRISPR, and Others ), by Application (Molecular Biology, Gene Synthesis, Gene Editing, Mammalian Protein Expression, Recombinant Antibody Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) ... Read More
Research Assistance
